PDT Partners’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
ACH
PDT Partners's VCYT Position: Q2 2025 in Review
PDT Partners sold out of Veracyte (VCYT) in Q2 2025, closing a stake of 69,066 shares — an estimated $2.05M sold.
PDT Partners first reported a position in VCYT in Q4 2017 and held it in 21 quarters. The position peaked at $4.36M in Q1 2021. 278 funds tracked by Wall St. Rank hold VCYT as of Q2 2025.
- PDT Partners reported no remaining Veracyte position as of Q2 2025 after selling out during the quarter.
- PDT Partners sold 69,066 Veracyte shares in Q2 2025, an estimated $2.05M.
- PDT Partners first reported a position in Veracyte in Q4 2017 and held it in 21 quarters.
- PDT Partners's Veracyte position peaked at $4.36M in Q1 2021.
- 278 funds tracked by Wall St. Rank held Veracyte as of Q2 2025.
Based on PDT Partners's 13F filing for Q2 2025, filed 14 Aug 2025.